Advertisement

Andrew McLachlan

Andrew McLachlan receives research funding from the NHMRC, research scholarship funding from GSK for a PhD student under his supervision and has previously received (and disclosed) in kind research support from Pfizer and GSK for investigator initiated research projects. Andrew serves and is paid as an expert on Australian government committees related to medicines regulation and anti-doping.
Andrew McLachlan receives research funding from the NHMRC, research scholarship funding from GSK for a PhD student under his supervision and has previously received (and disclosed) in kind research support from Pfizer and GSK for investigator initiated research projects. Andrew serves and is paid as an expert on Australian government committees related to medicines regulation and anti-doping.
Languages Spoken:
English

Explainer | Could a head lice drug hold the key to treating coronavirus?

Recent research data from scientists in Australia suggests Ivermectin is able to stop SARS-CoV-2, the virus that causes Covid-19, from replicating.

Related Topic
Coronavirus pandemic: All stories